Skip to main content
Addgene

pcDNA3 myc CIITA (P#808)
(Plasmid #14650)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 14650 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pcDNA3
  • Backbone manufacturer
    Invitrogen
  • Backbone size w/o insert (bp) 5500
  • Vector type
    Mammalian Expression
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    CIITA
  • Alt name
    class II transactivator
  • Species
    H. sapiens (human)
  • Entrez Gene
    CIITA (a.k.a. C2TA, CIITAIV, MHC2TA, NLRA)
  • Tag / Fusion Protein
    • Myc (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site EcoRI (not destroyed)
  • 3′ cloning site EcoRI (not destroyed)
  • 5′ sequencing primer T7
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Please note that mutations Q21E, V176M, S1023A in CIITA were found during Addgene's quality control process compared to GenBank: AAA88861.1. These mutations should not affect plasmid function, as described in the associated publication.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pcDNA3 myc CIITA (P#808) was a gift from Matija Peterlin (Addgene plasmid # 14650 ; http://n2t.net/addgene:14650 ; RRID:Addgene_14650)
  • For your References section:

    Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Kanazawa S, Okamoto T, Peterlin BM. Immunity. 2000 Jan . 12(1):61-70. 10.1016/S1074-7613(00)80159-4 PubMed 10661406